Cargando…
Preclinical Studies of the Potent and Selective Nicotinic α4β2 Receptor Ligand VMY-2-95
[Image: see text] The discovery and development of small molecules that antagonize neuronal nicotinic acetylcholine receptors may provide new ligands for evaluation in models of depression or addiction. We discovered a small molecule, VMY-2-95, a nAChR ligand with picomolar affinity and high selecti...
Autores principales: | Kong, Hyesik, Song, Jun-ke, Yenugonda, Venkata Mahidhar, Zhang, Li, Shuo, Tian, Cheema, Amrita K., Kong, Yali, Du, Guan-hua, Brown, Milton L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319692/ https://www.ncbi.nlm.nih.gov/pubmed/25533629 http://dx.doi.org/10.1021/mp5003569 |
Ejemplares similares
-
Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models
por: Yu, Ziru, et al.
Publicado: (2021) -
Author correction to ‘Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models’ [Acta Pharmaceutica Sinica B 11(2021) 1903–1913]
por: Yu, Ziru, et al.
Publicado: (2023) -
Author correction to ‘Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models’ [Acta Pharmaceutica Sinica B 11 (2021) 1903–1913]
por: Yu, Ziru, et al.
Publicado: (2023) -
Some interesting aspects of the VMI model
por: Scharff-Goldhaber, G
Publicado: (1970) -
VMI prueba Beery-Buktenica del desarrollo de la integración visomotriz y pruebas suplementarias de percepción visual y coordinación motriz
por: Beery, Keith E.
Publicado: (2000)